Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Long

Showing results (301-310 of 451) with videos related to

Pageof 46
Sort By:
Cancer Medicine|September 28, 2019
Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution studyCheng-Long Huang, Hong-Wen Tan, Rui Guo, et al.
Plos One|February 8, 2014
Thalamic GABA predicts fine motor performance in manganese-exposed smelter workersZaiyang Long, Xiang-Rong Li, Jun Xu, et al.
Cancer Medicine|April 6, 2019
The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy eraLing-Long Tang, Shao-Bo Liang, Cheng-Long Huang, et al.
Plos One|July 7, 2015
Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment ToxicitiesRui Guo, Ling-Long Tang, Yan-Ping Mao, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of chinaYong Chen, Meng-Zhong Liu, Shao-Bo Liang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Long-term Outcomes Following Individualized Primary Tumor Clinical Target Volume Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated With Intensity-Modulated RadiotherapyRui Guo, Wei-Wei Zhang, Jiawei Lv, et al.
Annals of Surgical Oncology|July 7, 2017
Refining the Role of Lymph Node Biopsy in Survival for Patients with Nasopharyngeal Carcinoma: Population-Based Study from the Surveillance Epidemiology and End-Results RegistryJia-Wei Lv, Guan-Qun Zhou, Yu-Pei Chen, et al.
Journal of Cancer|July 9, 2016
Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 CasesYuan Zhang, Hao Peng, Rui Guo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2017
Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy EraLing-Long Tang, Yu-Pei Chen, Yan-Ping Mao, et al.
Cancer Medicine|August 15, 2020
Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinomaCheng-Long Huang, Yang Chen, Rui Guo, et al.
Pageof 46

Showing results (301-310 of 451) with videos related to

Sort By:
Pageof 46
Cancer Medicine|September 28, 2019
Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution studyCheng-Long Huang, Hong-Wen Tan, Rui Guo, et al.
Plos One|February 8, 2014
Thalamic GABA predicts fine motor performance in manganese-exposed smelter workersZaiyang Long, Xiang-Rong Li, Jun Xu, et al.
Cancer Medicine|April 6, 2019
The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy eraLing-Long Tang, Shao-Bo Liang, Cheng-Long Huang, et al.
Plos One|July 7, 2015
Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment ToxicitiesRui Guo, Ling-Long Tang, Yan-Ping Mao, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of chinaYong Chen, Meng-Zhong Liu, Shao-Bo Liang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Long-term Outcomes Following Individualized Primary Tumor Clinical Target Volume Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated With Intensity-Modulated RadiotherapyRui Guo, Wei-Wei Zhang, Jiawei Lv, et al.
Annals of Surgical Oncology|July 7, 2017
Refining the Role of Lymph Node Biopsy in Survival for Patients with Nasopharyngeal Carcinoma: Population-Based Study from the Surveillance Epidemiology and End-Results RegistryJia-Wei Lv, Guan-Qun Zhou, Yu-Pei Chen, et al.
Journal of Cancer|July 9, 2016
Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 CasesYuan Zhang, Hao Peng, Rui Guo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2017
Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy EraLing-Long Tang, Yu-Pei Chen, Yan-Ping Mao, et al.
Cancer Medicine|August 15, 2020
Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinomaCheng-Long Huang, Yang Chen, Rui Guo, et al.
Pageof 46